CPT code 92607 covers the provider evaluation for prescription of a speech‑generating device and represents the first or only hour of that assessment. The code matters nationally because it documents a specialized, multidisciplinary evaluation that determines patient eligibility for Augmentative and Alternative Communication (AAC) technology and supports medical necessity for device coverage. Proper coding of this service affects access to communication aids for patients with severe speech impairment and influences payer medical review and reimbursement pathways.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and common modifiers affecting claim processing. The publication outlines benchmarks for utilization, common reasons for claim denials, and recent policy updates or payer guidance relevant to AAC evaluations. It also summarizes documentation elements typically required in the detailed report produced during the evaluation.

This summary is intended for clinicians, billing staff, and policy analysts seeking a national perspective on coding and coverage considerations for speech‑generating device evaluations under CPT code 92607.